bioRxivMicrobiologyPreprint
A Proteomics-Based Comparison of Host Responses to Spotted Fever Group Rickettsia in Endothelial Cells
Pedro CurtoiD, Cátia SantaiD, Bruno J. ManadasiD, Isaura SimõesiD
Abstract
Spotted fever group (SFG) Rickettsia species are obligate intracellular bacteria with a tropism for endothelial cells (ECs), where they initiate pathogenesis leading to rickettsial vasculitis. However, how endothelial cells sense and respond to infection by Rickettsia species of differing pathogenic potential remains poorly defined. In this study, we conducted a comparative analysis of four SFG Rickettsia species - R. africae, R. parkeri, R. massiliae, and R. montanensis - using high-throughput label-free SWATH/DIA-MS/MS in human HUVEC/TERT2 cells. Our results revealed distinct intracellular growth dynamics that correlated with known virulence profiles: the more pathogenic R. africae and R. parkeri replicated more efficiently, while the non-pathogenic R. montanensis failed to replicate. Proteomic profiling uncovered both shared and species-specific host responses, with a marked induction of proteins associated with type I interferon (IFN-I) signaling, particularly in response to R. africae and R. parkeri. Proteins typically involved in antiviral immunity, such as RIG-I, ISG15, IFITs, MX1, MX2, and OAS family members, were significantly accumulated, suggesting activation of cytosolic nucleic acid sensing pathways upon infection with pathogenic rickettsiae. ISGylation levels, however, remained low and varied depending on the species, pointing to complex regulatory mechanisms. Comparison with previous quantitative proteomics data in THP-1 macrophages revealed a conserved interferon signature, while also highlighting cell-type-specific responses. Overall, our findings demonstrate that endothelial cells activate innate immune pathways typically associated with antiviral defense upon Rickettsia infection. These immune signatures may serve as potential indicators of pathogenic potential and provide a foundation for identifying biomarkers and therapeutic targets in rickettsial diseases.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pathogenic Rickettsia species evade autophagosomal maturation and reduce anti-microbicidal pro-inflammatory IL-1 responses to support their intracellular survival.
- Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis.
T. P. Burke, P. Engstrom, … M. D. Welch·bioRxiv·Sep 23, 2020
- Pathogenic, but not non-pathogenic, Rickettsia evade inflammasome-dependent IL-1 responses to establish an intracytosolic replication niche.
O. H. Voss, J. Cobb, … A. F. Azad·bioRxiv·Sep 8, 2021
- DRP1/DMNL-1-mediated mitochondrial fission augments Rickettsia parkeri replication in macrophages
Natasha Kelly, Elliott Collins, … Juan J. Martinez·bioRxiv·Jun 25, 2025
- Inflammasome-mediated antagonism of type I interferon enhances Rickettsia pathogenesis
T. P. Burke, P. Engström, … M. D. Welch·bioRxiv·Jul 11, 2019
- Phosphatidylserine-binding receptor, CD300f, on macrophages mediates host invasion of pathogenic and non-pathogenic rickettsiae.
Oliver H. Voss, Imran Moin, … Mohammad Sayeedur Rahman·Infection and ImmunityPeer-reviewed·May 1, 2025